The table below shows Centessa Pharmaceuticals plc's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$72.22M
-$57.25M
-$37.29M
-$47.84M
-$50.02M
-$11.63M
Capital expenditure
-
-
$0.00
$88.00K
$240.00K
$37.00K
Investing cash flow
$42.71M
-$222.39M
$16.76M
-$86.34M
-$240.00K
$63.52M
Dividends paid
-
-
-
-
CNTA operating cash flow (10-K history)
Centessa Pharmaceuticals plc reported operating cash flow of -$193.82M for fiscal year 2025. That is down 36.4% from -$142.06M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$5.83M (FY 2019) to -$193.82M. Figures come from the company's audited annual reports as filed with the SEC.